Bayer initiates Phase III study program to investigate oral FXIa inhibitor asundexian
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke
Dr. Pedrocchi is currently an Independent Strategic Advisor and Non-Executive Director to private and public healthcare companies.
New mass spectrometry instrument and consumables launch during IMSC 2022
99% of Pristyn Doctors are using EMR facility on its doctor app
OrderPoint was designed as an advanced DTR solution from its first release in 2016.
Company appoints five new independent directors to reconstituted board
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
The WAVEsystem with the WAVEcontrol 4.0 embedded
Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
Subscribe To Our Newsletter & Stay Updated